TRANSAKT LTD.

CIK:0001263872|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Sales, net	$ 0	$ 0	$ 0	$ 0
Cost of sales	0	0	0	0
Gross profit	0	0	0	0
Selling, general and administrative expenses	(44,296)	(45,491)	(100,167)	(99,531)
Loss from operations	(44,296)	(45,491)	(100,167)	(99,531)
Other income (expense)
Interest income/ (expense)	0	0	0	0
Currency exchange gain (loss)	(11)	(102)	(76)	(108)
Other income	0	0	0	0
Total other income (expenses)	(11)	(102)	(76)	(108)
(Loss)/ Profit before income taxes	(44,307)	(45,593)	(100,243)	(99,639)
Provision for income taxes expense (benefit)	0	0	0	0
Net (loss)/ profit	(44,307)	(45,593)	(100,243)	(99,639)
Net gain (loss) attributable to non- controlling interest	0	0	0	0
Net (loss)/ profit attributable to TRANSAKT	$ (44,307)	$ (45,593)	$ (100,243)	$ (99,639)
Loss per share:
Basic and diluted income (loss) common stockholders per share Net loss (in dollars per share)	$ (0.0003)	$ (0.0003)	$ (0.0007)	$ (0.0007)
Weighted average number of shares outstanding:
Basic and diluted (in shares)	133,506,570	133,506,570	133,506,570	133,506,570
Other Comprehensive Income (Loss)
Net loss	$ (44,307)	$ (45,593)	$ (100,243)	$ (99,639)
Foreign currency translation adjustment	(10)	43	367	71
Comprehensive income (loss)	(44,317)	(45,550)	(99,876)	(99,568)
Comprehensive income (loss) attributable to the non-controlling interest	0	0	0	0
Comprehensive income (loss) attributable to TRANSAKT LTD.	$ (44,317)	$ (45,550)	$ (99,876)	$ (99,568)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities
Net gain (loss) available to common stockholders	$ (100,243)	$ (99,639)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest expenses	0	0
Changes in assets and liabilities:
Decrease (Increase) in prepayments	12,000	10,000
Decrease (Increase) in deposits	0	0
Increase (Decrease) in accounts payable and accrued expenses	(10,631)	(14,271)
Net cash used in operating activities	(98,874)	(103,910)
Cash flows from investing activities
Net cash used in investing activities	0	0
Cash flows from financing activities
Due to related party	0	0
Net cash provided by financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	367	71
Net increase (decrease) in cash and cash equivalents	(98,507)	(103,839)
Cash and cash equivalents
Beginning	227,088	435,630
Ending	128,581	331,791
Non cash financing activities
Issuance of common stock to settle convertible promissory note and its relevant accrued interest	0	0
Cash paid during the year for:
Income tax	0	0
Interest expense	$ 0	$ 0

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 128,581	$ 227,088
Prepayments		12,000
Total Current Assets	128,581	239,088
Total Assets	128,581	239,088
Current Liabilities
Accrued expenses	26,656	37,287
Total Current Liabilities	26,656	37,287
Total liabilities	26,656	37,287
Stockholders' Equity
Common stock, 700,000,000 shares authorized for issuance, $0.001 par value, 133,506,570 shares issued and outstanding at June 30, 2019 and December 31 2018, respectively	133,506	133,506
Additional paid-in capital	24,265,011	24,265,011
Accumulated deficit	(22,659,079)	(22,558,836)
Other comprehensive income	(437,513)	(437,880)
Stock subscription receivable	(1,200,000)	(1,200,000)
Total Stockholders' Equity	101,925	201,801
Non-controlling interest
Total Equity	101,925	201,801
Total Liabilities and Equity	$ 128,581	$ 239,088